AGP Executive Report
Last update: 8 hours agoWeight-loss drug news: An experimental daily pill reported over 10% body-weight loss in six months, with related research also pointing to GLP-1 options that may improve blood sugar in type 2 diabetes. Public health in Taiwan: Taiwan’s CDC reported first 2026 cases of Japanese encephalitis and paratyphoid fever, urging mosquito protection and vaccination ahead of peak season. Care access: Taipei announced free health checkups for migrant workers at Taipei Railway Station, with screenings plus dental, ENT, internal medicine, gynecology, psychiatry and traditional Chinese medicine. Health tech & biotech: Antengene said China’s NMPA approved an IND for ATG-201 (CD19×CD3 TCE) for B-cell autoimmune diseases, setting up Phase I work. AI investment with health links: SK Telecom, NTT and Chunghwa Telecom plan a $500m AI fund targeting data centers, semiconductors and AI services, including health care applications. Workplace health & safety: A Singapore maid agency was ordered to pay after falsely claiming a helper could speak Mandarin, highlighting the real-world impact of care-related misrepresentation. Disaster risk: A 7.8 quake in the Philippines triggered tsunami warnings across parts of the western Pacific, including Taiwan.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
